Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA

BRCA1- and BRCA2-associated hereditary breast and ovarian cancer syndromes are among the best-known and most extensively studied hereditary cancer syndromes. Nevertheless, many patients who proved negative at BRCA genetic testing bring pathogenic mutations in other suppressor genes and oncogenes ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Piombino, Claudia, Cortesi, Laura, Lambertini, Matteo, Punie, Kevin, Grandi, Giovanni, Toss, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376433/
https://www.ncbi.nlm.nih.gov/pubmed/32733558
http://dx.doi.org/10.1155/2020/6384190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376433/
https://www.ncbi.nlm.nih.gov/pubmed/32733558
http://dx.doi.org/10.1155/2020/6384190

Ejemplares similares